These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 19429588)

  • 1. Mantle cell lymphoma in the orbital and adnexal region.
    Rasmussen P; Sjö LD; Prause JU; Ralfkiaer E; Heegaard S
    Br J Ophthalmol; 2009 Aug; 93(8):1047-51. PubMed ID: 19429588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mantle cell lymphoma in the ocular adnexal region.
    Looi A; Gascoyne RD; Chhanabhai M; Connors JM; Rootman J; White VA
    Ophthalmology; 2005 Jan; 112(1):114-9. PubMed ID: 15629830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK
    Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffuse large B-cell lymphoma of the ocular adnexal region: a nation-based study.
    Rasmussen PK; Ralfkiaer E; Prause JU; Sjö LD; Toft PB; Siersma VD; Heegaard S
    Acta Ophthalmol; 2013 Mar; 91(2):163-9. PubMed ID: 22551232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome and prognostic factors in ocular adnexal lymphoma.
    Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
    Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features associated with survival of patients with lymphoma of the ocular adnexa.
    Jenkins C; Rose GE; Bunce C; Cree I; Norton A; Plowman PN; Moseley I; Wright JE
    Eye (Lond); 2003 Oct; 17(7):809-20. PubMed ID: 14528242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological Features of Ocular Adnexal Mantle-Cell Lymphoma in an International Multicenter Cohort.
    Knudsen MKH; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Khong JJ; McKelvie PA; Mulay K; Ralfkiaer E; Sjö LD; Vemuganti GK; Thuro BA; Curtin J; Heegaard S
    JAMA Ophthalmol; 2017 Dec; 135(12):1367-1374. PubMed ID: 29121219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follicular lymphoma of the ocular adnexal region: a nation-based study.
    Rasmussen PK; Ralfkiaer E; Prause JU; Sjö LD; Specht L; Rossing HH; Siersma VD; Heegaard S
    Acta Ophthalmol; 2015 Mar; 93(2):184-91. PubMed ID: 25125069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa.
    Lee JL; Kim MK; Lee KH; Hyun MS; Chung HS; Kim DS; Shin SO; Cho HS; Bae SH; Ryoo HM
    Ann Hematol; 2005 Jan; 84(1):13-8. PubMed ID: 15309523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orbital lymphoproliferative tumors: analysis of clinical features and systemic involvement in 160 cases.
    Demirci H; Shields CL; Karatza EC; Shields JA
    Ophthalmology; 2008 Sep; 115(9):1626-31, 1631.e1-3. PubMed ID: 18440641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular adnexal follicular lymphoma: a multicenter international study.
    Rasmussen PK; Coupland SE; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; McKelvie P; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Heegaard S
    JAMA Ophthalmol; 2014 Jul; 132(7):851-8. PubMed ID: 24763920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of eukaryotic initiation factor 4E predicts clinical outcome in patients with mantle cell lymphoma treated with hyper-CVAD and rituximab, alternating with rituximab, high-dose methotrexate, and cytarabine.
    Inamdar KV; Romaguera JE; Drakos E; Knoblock RJ; Garcia M; Leventaki V; Medeiros LJ; Rassidakis GZ
    Cancer; 2009 Oct; 115(20):4727-36. PubMed ID: 19708031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly effective local control and palliation of mantle cell lymphoma with involved-field radiation therapy (IFRT).
    Rosenbluth BD; Yahalom J
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1185-91. PubMed ID: 16682133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ophthalmic lymphoma: epidemiology and pathogenesis.
    Sjö LD
    Acta Ophthalmol; 2009 Feb; 87 Thesis 1():1-20. PubMed ID: 19178392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristics of ocular adnexal non-Hodgkin lymphoma].
    Yi WS; Xu XL; Xiang Q; Jiang HB
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 33(9):826-30. PubMed ID: 18812662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraocular lymphoma: a series of 14 patients with clinicopathological features and treatment outcomes.
    Hoffman PM; McKelvie P; Hall AJ; Stawell RJ; Santamaria JD
    Eye (Lond); 2003 May; 17(4):513-21. PubMed ID: 12802353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mantle cell lymphoma of the maxillary sinus invading the orbit.
    Nagel-Esposito AD; Kawasaki B; Jew R; Fujimoto L
    Optometry; 2011 Jan; 82(1):22-31. PubMed ID: 21146791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blastoid variant of mantle cell lymphoma: late progression from classical mantle cell lymphoma and quantitation of minimal residual disease.
    Pott C; Schrader C; Brüggemann M; Ritgen M; Harder L; Raff T; Tiemann M; Dreger P; Kneba M
    Eur J Haematol; 2005 Apr; 74(4):353-8. PubMed ID: 15777349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy in mantle cell lymphoma: anti-CD20-based therapy and beyond.
    Zhou Y; Zhang L; Romaguera J; Delasalle K; Han X; Du X; Kwak L; Yi Q; Wang M
    Am J Hematol; 2008 Feb; 83(2):144-9. PubMed ID: 17722077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCL10 expression in ocular adnexal lymphomas.
    Vejabhuti C; Harris GJ; Erickson BA; Nishino H; Chevez-Barrios P; Chang CC
    Am J Ophthalmol; 2005 Nov; 140(5):836-843. PubMed ID: 16310461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.